Thiazide Prophylaxis for Kidney Stones Doesn't Increase DM Risk

This article originally appeared here.
Share this content:
Thiazide Prophylaxis for Kidney Stones Doesn't Increase DM Risk
Thiazide Prophylaxis for Kidney Stones Doesn't Increase DM Risk

MONDAY, Dec. 22, 2014 (HealthDay News) -- The risk of diabetes mellitus is not increased with thiazide diuretic prophylaxis for kidney stones, according to research published in the December issue of The Journal of Urology.

Prince Singh, from the Mayo Clinic in Rochester, Minn., and colleagues identified and validated incident stone formers in Olmsted County, Minn., from 1984 to 2011. The authors examined the risk of diabetes, with and without multivariate adjustment, after thiazide therapy.

The researchers found that 14 percent of the 2,350 incident stone formers were treated with thiazide diuretics at some point after the first stone event, and the thiazide diuretic was received only for kidney stone prevention in 3.6 percent. For those receiving and not receiving thiazide diuretics, the incidence of diabetes mellitus at 10 years after first stone event was 9.2 and 4.2 percent, respectively (hazard ratio [HR], 2.91; 95 percent confidence interval [CI], 2.02 to 4.20). The risk of diabetes was attenuated after multivariate adjustment (HR, 1.20; 95 percent CI, 0.78 to 1.83). There was further attenuation of risk among those receiving thiazide diuretics only for kidney stones (HR, 0.80; 95 percent CI, 0.28 to 2.23).

"Thiazide diuretic use for kidney stone prophylaxis was not associated with a high risk of diabetes mellitus," the authors write. "Larger studies are needed to determine if there is a modest risk of diabetes mellitus with thiazide diuretics."

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

Medicaid Expansion Ups Preemptive Listing for Kidney Transplant

Medicaid Expansion Ups Preemptive Listing for Kidney Transplant

From pre- to post-expansion period, 59 percent relative increase in Medicaid-covered preemptive listings

BCG Vaccine Tied to Reduced Hyperglycemia in Type 1 Diabetes

BCG Vaccine Tied to Reduced Hyperglycemia in Type ...

Systemic shift in glucose metabolism from oxidative phosphorylation to aerobic glycolysis

Many Physicians Not Prepared for End-of-Life Talks With Patients

Many Physicians Not Prepared for End-of-Life Talks With ...

Additional training, reimbursement may foster these critical conversations, authors say

is free, fast, and customized just for you!




Already a member?

Sign In Now »